MRRCF - Wayland Group

Other OTC - Other OTC Delayed Price. Currency in USD
0.8000
-0.0499 (-5.87%)
As of 2:27PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close0.8499
Open0.8265
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.8000 - 0.8570
52 Week Range0.8000 - 3.6000
Volume94,246
Avg. Volume257,503
Market Cap169.279M
Beta (3Y Monthly)7.80
PE Ratio (TTM)N/A
EPS (TTM)-0.26
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire2 days ago

    REPEAT - Wayland Group Announces Strategic Acquisition in Argentina

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce it has entered into an agreement to purchase 819 hectares of existing developed agriculture land in San Juan Province in Argentina. San Juan Province is ideal for cannabis cultivation due to the province’s climate and altitude. The presence of a stable economy and infrastructure to support business development is another contributing factor for the Company’s interest in the country.

  • GlobeNewswire3 days ago

    Wayland Group Announces Strategic Acquisition in Argentina

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce it has entered into an agreement to purchase 819 hectares of existing developed agriculture land in San Juan Province in Argentina. San Juan Province is ideal for cannabis cultivation due to the province’s climate and altitude. The presence of a stable economy and infrastructure to support business development is another contributing factor for the Company’s interest in the country.

  • iAnthus Capital Holdings’ Valuation as of November 30
    Market Realist10 days ago

    iAnthus Capital Holdings’ Valuation as of November 30

    iAnthus Capital Holdings (ITHUF) is a leading company in the cannabis industry (SEED). This article compares iAnthus Capital’s valuation to those of its peers, including MPX Bioceutical (MPXEF), MariCann (MRRCF), and MedMen (MMNFF).

  • GlobeNewswire10 days ago

    Wayland Enters the Asia-Pacific Market with Australian Acquisition

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce its expansion into Australia, through entering into an agreement to acquire 50.1% of Tropicann Pty Ltd. (“Tropicann”), a newly formed, privately owned Australian company located in Darwin, Northern Territory, to partner with industry leaders in Australia’s expanding cannabis industry. With this acquisition Wayland has positioned itself in the important and burgeoning Asia-Pacific market. “Globalization of cannabis continues, and we are present in relevant markets, with Asia-Pacific now added to our international footprint.

  • GlobeNewswire15 days ago

    Wayland Reports Q3 2018 Results

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) has reported its financial and operating results for the third quarter ended September 30, 2018 and has filed the full report on SEDAR. "Consistent with previous guidance, we reserved product for European export and the recreational market in Canada, which legalized cannabis for adult use on October 17th.

  • Curaleaf Holdings’ Valuation following Its Q3 Results
    Market Realist15 days ago

    Curaleaf Holdings’ Valuation following Its Q3 Results

    In this article, we’ll discuss Curaleaf Holdings’ (LDVTF) valuation as of November 27 and its comparison with its peers, including WeedMD (WDDMF), Trulieve (TCNNF), and Maricann (MRRCF).

  • Curaleaf’s Performance in the First Nine Months of 2018
    Market Realist16 days ago

    Curaleaf’s Performance in the First Nine Months of 2018

    As we discussed in the previous article, Curaleaf Holdings (LDVTF), one of the leading cannabis operators in the United States, released its third-quarter earnings results on November 26. Curaleaf Holdings reported a 247% increase in its revenue to $45.1 million in the first nine months of 2018 compared to $13.0 million in the same period of 2017. Its revenue in the first nine months of 2018 was $55.0 million on a pro forma basis when consolidated for nonprofit entities.

  • How Cannabis Stocks Performed in Week 47
    Market Realist17 days ago

    How Cannabis Stocks Performed in Week 47

    In this part of our series, we take a look at the stock performance of must-know Cannabis stocks Curaleaf Holdings (LDVTF), Trulieve (TCNNF), WeedMD (WDDMF), Maricann (MRRCF), MedMen (MMNFF), Golden Leaf Holdings (GLDFF), and Vivo Cannabis (VVCIF) over the last week.

  • Developments in Cannabis Stocks during Week 47
    Market Realist17 days ago

    Developments in Cannabis Stocks during Week 47

    The Cannabis stocks we discuss in this series include WeedMD (WDDMF), Curaleaf Holdings (LDVTF), Trulieve (TCNNF), Maricann (MRRCF), MedMen (MMNFF), Golden Leaf Holdings (GLDFF), and Vivo Cannabis (VVCIF). Let’s take a look at the must-know developments and stock price performance for these companies last week.

  • GlobeNewswire17 days ago

    REPEAT - Wayland Group Enters the United Kingdom

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce it has entered into an agreement to acquire 51% of UK based Theros Pharma Ltd. ("Theros"), an early stage company that has successfully imported cannabis to the UK for patients with a prescription for medical cannabis. This transaction enhances Wayland’s global growth strategy and will provide the Company with access to the UK market for sale and distribution of its products. Recent UK legislation allows for the prescription of cannabis from a medical specialist via a regular pharmacy model.

  • GlobeNewswire18 days ago

    Wayland Group Enters the United Kingdom

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce it has entered into an agreement to acquire 51% of UK based Theros Pharma Ltd. ("Theros"), an early stage company that has successfully imported cannabis to the UK for patients with a prescription for medical cannabis. This transaction enhances Wayland’s global growth strategy and will provide the Company with access to the UK market for sale and distribution of its products. Recent UK legislation allows for the prescription of cannabis from a medical specialist via a regular pharmacy model.

  • MedMen’s Valuation versus Its Peers’
    Market Realist24 days ago

    MedMen’s Valuation versus Its Peers’

    MedMen Enterprises (MMNFF) holds 19 licensed cannabis facilities for cultivation, manufacturing, and marketing cannabis as a consumer product. This article compares MedMen’s (MMNFF) valuation with its peers’, including Tilray (TLRY), CannaRoyalty (OH), and Maricann (MRRCF).

  • GlobeNewswire24 days ago

    Wayland Group Announces Appointment of General Counsel

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce the appointment of Matthew McLeod who will assume the role of General Counsel. The Company is pleased to welcome Matthew to the newly created role. Mr. McLeod was called to the Ontario bar in 2013 and the New York bar in 2014, holds a BEng and an MBA from the Royal Military College of Canada as well as a JD from Western University.

  • Reviewing MedMen’s 2018 Performance
    Market Realist27 days ago

    Reviewing MedMen’s 2018 Performance

    MedMen Enterprises (MMNFF), a the cannabis company, has 19 licensed cannabis facilities for cultivation, manufacturing, and marketing cannabis as a consumer product.

  • GlobeNewswirelast month

    REPEAT - Wayland Group Announces Definitive Agreement for Italian Joint Venture

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce it has completed a definitive joint venture agreement with CBD Italian Factory S.S., a company of Group San Martino for the production of high quality cannabis products in Italy. The joint venture will marry the best of both entities with world-leading technology by Rockwell Automation paired with existing infrastructure in Piedmont, Italy, which includes agricultural expertise and biogas electricity. This will allow the sustainable production of quality CBD and THC products from a naturally derived fuel source.

  • GlobeNewswirelast month

    Wayland Group Announces Definitive Agreement for Italian Joint Venture

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce it has completed a definitive joint venture agreement with CBD Italian Factory S.S., a company of Group San Martino for the production of high quality cannabis products in Italy. The joint venture will marry the best of both entities with world-leading technology by Rockwell Automation paired with existing infrastructure in Piedmont, Italy, which includes agricultural expertise and biogas electricity. This will allow the sustainable production of quality CBD and THC products from a naturally derived fuel source.

  • GlobeNewswirelast month

    Wayland Group Announces Closing of Over-Allotment Option for Additional Gross Proceeds of $7.5 Million

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) announced today that, further to its press release dated October 31, 2018 and in connection with its previously announced bought deal financing, it has issued an additional 4,552,500 Units (the “Units”) at a price of $1.65 per Unit (the “Offering Price”) for total gross proceeds of $7,511,625, pursuant to the exercise in full of the Underwriters’ over-allotment option. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements.

  • GlobeNewswirelast month

    REPEAT - Wayland Group Announces Changes to the Board

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to welcome Mr. Clay Horner and Mr. Rudolph (Rudi) Hilti to the board, which will strengthen and improve corporate governance, global strategy, finance, and M&A expertise. Additionally, Paul Pathak has now been appointed Chairman of the Board. Clay Horner is a principal of HBH Strategic Advisors which consults on significant   business and corporate matters for several large private equity firms and domestic and international corporations.

  • GlobeNewswirelast month

    REPEAT - Wayland Group Enters into Agreement to Expand Global Footprint with Acquisition in Colombia

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company) is pleased to announce that the Company has entered the South American market through a transaction in Colombia. Wayland has entered into a definitive agreement to acquire 100% of the outstanding shares of Colma Pharmaceutical SAS (“Colma”), a licenced producer of THC cannabis in Colombia, holding four licences for cultivation and processing on a leased premise in Ibague, Colombia. Under the terms of the agreement, Wayland will issue 11 million common shares as consideration for the shares of Colma with shares being issued at a deemed price of CAD$2.00 per share.

  • GlobeNewswirelast month

    Wayland Group Enters into Agreement to Expand Global Footprint with Acquisition in Colombia

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company) is pleased to announce that the Company has entered the South American market through a transaction in Colombia. Wayland has entered into a definitive agreement to acquire 100% of the outstanding shares of Colma Pharmaceutical SAS (“Colma”), a licenced producer of THC cannabis in Colombia, holding four licences for cultivation and processing on a leased premise in Ibague, Colombia. Under the terms of the agreement, Wayland will issue 11 million common shares as consideration for the shares of Colma with shares being issued at a deemed price of CAD$2.00 per share.

  • GlobeNewswirelast month

    Wayland Group Announces Closing of Previously Announced Bought Deal Financing Raising Gross Proceeds of $50 Million

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) announced today that it has closed its previously announced bought deal financing of units (the “Units”) at a price of $1.65 per Unit (the “Offering Price”) for aggregate gross proceeds of $50,077,500 (the “Offering”). Each Unit consists of one common share (a "Common Share") and one-half of one common share purchase warrant (each full common share purchase warrant, a "Warrant") of the Company. Each Warrant is exercisable to acquire one Common Share for a period of three years at an exercise price of $2.15 per Common Share, subject to adjustment in certain events.

  • GlobeNewswire2 months ago

    Wayland Group Receives Receipt for Final Prospectus for Previously Announced Bought Deal Financing

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) announced today that it has received a receipt for a final prospectus (the "Prospectus") of the Company from the securities regulators in each of the provinces of Canada (other than Quebec) with respect to its previously announced $50,000,000 bought deal offering of units of the Company (the "Offering"). The Offering is expected to close on October 31, 2018 and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including approval of the Canadian Securities Exchange and applicable securities regulatory authorities.  The Company intends to use the net proceeds from the Offering for expansion of its facility at 138, 8th Concession Road in Langton, Ontario and for working capital and general corporate purposes.

  • GlobeNewswire2 months ago

    Wayland Reports Harvest Results from Mariplant GmbH

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company“) is pleased to provide the following update regarding the Company’s hemp operations in Germany. Wayland has completed its hemp harvest in Germany, harvesting 135 of the 165 hectares planted.  The amount of dry hemp flowers recovered and suitable for processing into resin totaled 120,615 kg, outperforming internal forecasts by a factor of almost two. The Company expects to maintain stock for its differentiated VESIsorb® product line available at www.mariplant.de.

  • GlobeNewswire2 months ago

    Wayland Releases Portfolio of Brands & Receives Sales License from Health Canada for Expansion Site

    Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company“) is excited to announce the release of its portfolio of brands that cater to different ages, genders, and occasions. The Company’s extensive research created a portfolio of brands, each designed to address segments of the cannabis market both present and future.  Strategically using each of these brands, Wayland gave itself the ability to be present and relevant to consumers. “The advent of recreational cannabis legalization in Canada is truly a watershed moment for Canadians.